| Ohio State Medical Center - YouTube, accessed April 21, 2025, Study identifies 3 strategies to minimize muscle loss from GLP-1 weight loss drugs, accessed April 21, 2025, pmc.ncbi.nlm.nih.gov, accessed April 21, 2025, GLP1 receptor agonists for the treatment of obesity: Role as a promising approach, accessed April 21, 2025, Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists - Frontiers, accessed April 21, 2025, Effects of Weight Loss on Lean Mass, Strength, Bone, and Aerobic Capacity - PMC, accessed April 21, 2025, Preserving Healthy Muscle during Weight Loss - PMC, accessed April 21, 2025, Boosting BCL6 may counteract muscle loss from GLP-1 medications, accessed April 21, 2025, Muscle Loss and GLP-1s: Why It Matters and How To Address It - Vori Health, accessed April 21, 2025, Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies - PubMed, accessed April 21, 2025, Semaglutide and GLP-1: Effects on lean body mass still unclear, accessed April 21, 2025, Normative vs Excess Muscle Loss and Strength with GLP-1 Medications vs Other Weight Loss Methods - Ro, accessed April 21, 2025, Does Ozempic cause muscle loss and how to prevent it

Abstract The glucagon-like peptide-1 receptor (GLP-1R) has broad physiological roles and is a validated target for treatment of metabolic disorders
The most challenging transition for most people is the jump from 0.25 mg to 0.5 mg because it is the first time the body encounters a dose that significantly affects gastric emptying
Some people benefit from weekly or biweekly injections during high-stress periods, frequent travel, or when recovering from illness
'Very important' and 'critical' contribution Canada has played a major role in the area of diabetes treatment, Ur said